Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Isocyanates are a class of highly reactive organic compounds characterized by the isocyanate functional group (–N=C=O). They serve as key building blocks in the chemical synthesis of polyurethanes, adhesives, coatings, foams, and elastomers, primarily in industrial and manufacturing contexts[1][4][5]. Representative molecules include toluene diisocyanate (TDI), methylene diphenyl diisocyanate (MDI), and hexamethylene diisocyanate (HMDI)[5][6][7]. Isocyanates do not serve as biological targets for drugs or therapeutics, and exposure poses notable health risks including sensitization, respiratory disease, and potential carcinogenicity[1][8]. In summary, while isocyanates are important industrial chemicals, they are not considered bioreceptors, enzymes, or therapeutic targets, and the query reflects a category error. For therapeutic target information, the name should refer to a specific protein, receptor, enzyme, or other well-defined biomolecule.
not a drug target; reacts chemically with nucleophiles: alcohols, amines, acids, and bases
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Isocyanate (NCO).